This SPAC is merging with an already-public company as sponsors get creative before time runs out - CNBC

Many sponsors face challenges as they race the clock to find a target amid regulatory crackdown and waning enthusiasm.

SPACs are known to be a roundabout investment vehicle to take private companies public. Not this one. Bull Horn Holdings is merging with biotech Coeptis Therapeutics, a public company traded over th… [+2201 chars]

full article...